17th Annual Public Health Leadership Forum: Stigma and Illness
The bias and discrimination that accompany certain illness can prevent individuals from seeking care, engender fear, and cause prejudice against entire groups or communities. The response to outbreaks, infectious disease, and stereotyped health conditions requires protecting health whilst mitigating the stigma that can further exacerbate social and health disparities. The 17th Annual Public Health Leadership Forum (previously recorded on October 29, 2020) convened leaders in public health, medicine, policy, government, and the community to examine ways to destigmatize disease and put forth interventions that reinforce prevention and the provision of safe, equitable, and quality health care.
This activity is designed for health care leaders, physicians, residents, other health care professionals and students in all health care professions.
- Describe how social stigma of disease undermines early detection, treatment, and successful health outcomes
- Examine how stigmatizing disease exacerbates social and health disparities
- Develop appropriate skills to evaluate epidemiological data without engendering fear of certain populations including ethnic, racial, or socioeconomic groups
- Assess the role of physicians as leaders in reducing disease and illness related discrimination
David Rosman, MD, MBA
President, Massachusetts Medical Society
James B. Broadhurst, MD, MHA
Chair, Committee on Public Health, Massachusetts Medical Society
Harold Cox, MSSW
Associate Professor, Community Health Sciences Boston University School of Public Health
Anne Stangl, PhD
President, Hera Solutions, LLC, Associate Faculty, Social and Behavioral Interventions, Johns Hopkins Bloomberg School of Public Health.
Cassandra Pierre, MD, MPH
Medical Director, Center for Infectious Diseases, Boston Medical Center
Michael Curry, Esq.,
Deputy CEO & General Counsel Massachusetts League of Community Health Centers
Accreditation and Credit Information
The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Massachusetts Medical Society designates this internet enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for the Massachusetts Board of Registration in Medicine for risk management study.
MOC Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, this activity has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
Allergy and Immunology
Medical Genetics and Genomics
Physical Medicine and Rehabilitation
Psychiatry and Neurology
National Commission on Certification of Physicians Assistant (NCCPA)
Physician Assistants may claim a maximum of 2.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society.
Exam/Assessment: A score of 70% or higher is required to receive AMA PRA Category 1 Credits™.
- 2.25 MOC II
- 2.25 AMA PRA Category 1 Credit™
This course is offered through Massachusetts Medical Society.
To take this course you will be redirected to Massachusetts Medical Society's website. You must login or create an account with Massachusetts Medical Society in order to complete this activity.
Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!